Table of Contents
<< Previous Issue | Jul 2019 (Vol: 2019, Issue: 7) | Next Issue >> |
- Section: Licensing
-
Gilead Deepens R&D Investment with US$10 B Galapagos Deal
- Section: Mergers & Acquisitions
-
AbbVie Acquires Allergan for US$63 B to Ease Humira Fears
- Section: Research & Development
-
Skyhawk Signs its First Oncology Deal with Merck
-
Genentech on a Discovery Spree with Skyhawk, Convelo and Sosei Heptares Deals
-
Astellas Gains Hearing Disorder Therapy from Frequency Therapeutics
-
Boehringer Ingelheim Strikes Third Deal of the Month with Bridge Biotherapeutics